0.3856  -0.003 (-0.87%)		06-12 16:00
Open: 0.3961 High: 0.4 Volume: 80,921		Pre. Close: 0.389 Low: 0.3711 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	0.49	1-year :	0.57
Resists	First :	0.42	Second :	0.49
Pivot price	0.4
Supports	First :	0.28	Second :	0.2
MAs	MA(5) :	0.39	MA(20) :	0.38
	MA(100) :	0.39	MA(250) :	0.79
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	60.2	D(3) :	74.1
RSI	RSI(14): 49.8
52-week	High :	2.64	Low :	0.2

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AMIX ] has closed above bottom band by 13.0%. Bollinger Bands are 51.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.4 - 0.4	0.4 - 0.4
Low:	0.37 - 0.37	0.37 - 0.37
Close:	0.38 - 0.39	0.39 - 0.39

Autonomix Medical, Inc. is an emerging medical device company focused on developing advanced solutions for identifying and treating various disorders impacting the peripheral nervous system. At the core of its innovation is a sophisticated technology platform that incorporates a catheter-based, microchip-enabled sensing array, engineered to precisely detect and differentiate peripheral neural signals. This Texas-based firm, headquartered in The Woodlands, was established in 2014.

Mon, 08 Jun 2026
Autonomix Medical (AMIX) Faces Continued Pressure Near $0.40 Support Level - Delta Hedging - newsline.com

Mon, 08 Jun 2026
Autonomix Medical (AMIX) Faces Continued Pressure Near $0.40 Support Level - Initial Balance - newsline.com

Thu, 31 Jul 2025
Should I buy Autonomix Medical, Inc. (AMIX) - Zacks Investment Research

Tue, 29 Jul 2025
AMIX Stock Price and Chart — NASDAQ:AMIX - TradingView

Thu, 24 Apr 2025
AMIX Stock Price, News & Analysis - Stock Titan

Thu, 17 Apr 2025
Autonomix Medical Expands Team with Strategic 5,000-Share Stock Option Grant to New Key Employee - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	11 (M)
Shares Float	11 (M)
Held by Insiders	4 (%)
Held by Institutions	4.1 (%)
Shares Short	646 (K)
Shares Short P.Month	231 (K)

EPS	-2.32
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.51
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-122.4 %
Return on Equity (ttm)	-238.9 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-1.5
Qtrly Earnings Growth	0 %
Operating Cash Flow	-12 (M)
Levered Free Cash Flow	-6 (M)

PE Ratio	-0.17
PEG Ratio	0
Price to Book value	0.74
Price to Sales	0
Price to Cash Flow	-0.36

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.